Health

"Promoting Health, Wellness, and Community: Gowalking.com Unites Global Fitness Walkers for a Better World"

BOCA RATON, Fla., Sept. 12, 2023 /PRNewswire/ -- Today marks the launch of Gowalking.com, a groundbreaking start-up founded byJeremy Goldstein, with a mission to connect and empower the world's estimated 1.2 billion fitness walkers by providing a simple and innovative platform for finding and joi...

2023-09-12 22:30 2902

Frost & Sullivan Recognizes Suki AI with the 2023 North American Technology Leadership Award

Suki's innovative AI Assistant brings the power of Generative AI to health systems and delivers strong ROI SAN ANTONIO, Sept. 12, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the healthcare voice assistant industry and, based on its findings, recognizesSuki AI with the 2023 North Am...

2023-09-12 22:00 1843

TMRW Life Sciences Receives CE Mark for the CryoRobot Select, its Next-Generation Automated Platform to Safely Manage and Store Frozen Eggs and Embryos

TMRW's Cutting-Edge Technology is Raising the Standard of Care in Global Fertility NEW YORK, Sept. 12, 2023 /PRNewswire/ -- TMRW Life Sciences, a fertility technology company automating the IVF lab, today announced that it has received a CE Mark for the CryoRobot Select (CRS). The European desig...

2023-09-12 21:01 1739

CSafe Expands Executive Team with Chief Financial Officer

Seasoned financial leader, Anthony Pishotti, joins CSafe executive team to further drive the company's portfolio and geographic growth. MONROE, Ohio, Sept. 12, 2023 /PRNewswire/ -- CSafe, the largest active and passive temperature-controlled shipping solutions provider for the biopharmaceutical ...

2023-09-12 20:59 2185

Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media

News Summary: * Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and Andrew+™ robot with upstream bioreactors to automate routine product quality and cell culture media analyses. * New pre-developed LC-MS analytical workflow...

2023-09-12 20:00 1860

New South Wales Government (NSW) Partner, Myeloid Therapeutics, Initiates Patient Dosing with MT-302 in Phase 1 Study at Clinical Site in Australia

NSW and Myeloid entered into a partnership in February 2023 to launch state-of-the-art GMP manufacturing RNA facility CAMBRIDGE, Mass., Sept. 12, 2023 /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage oncology company, has dosed the first patient with MT-302 in a Phase 1 s...

2023-09-12 20:00 1092

Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration

CASTRES, France and BASEL, Switzerland, Sept. 12, 2023 /PRNewswire/ --  Pierre Fabre Laboratories , the French pharmaceutical and dermo-cosmetic company, announced the acquisition of Vertical Bio AG, a developer of novel cancer therapies. This first acquisition of...

2023-09-12 20:00 1541

Metabolon Launches New Biological Stress Discovery Panel to Aid Detection of Inflammation and Biological Stress Biomarkers

Metabolon's new Biological Stress Discovery Panel supports inflammation, immune function, and stress research with advanced analytics  MORRISVILLE, N.C., Sept. 12, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, di...

2023-09-12 19:57 1159

The Korean Society of Ginseng confirms the effects of consuming red ginseng in the prevention and improvement of dementia

- Through the study "Elucidation of Mechanisms for Dementia Prevention and Improvement by Red Ginseng" SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- Through continuous research, the secrets of ginseng, a representative medicinal herb of Korea, are being revealed, showcasing its efficacy. Re...

2023-09-12 17:00 2066

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

* Lunit's collaborative study supports AI as a viable alternative to one human reader inEurope's double reading system - published in The Lancet Digital Health SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagno...

2023-09-12 13:03 2164

Gates Foundation Goalkeepers Report Says Seven Innovations Could Save 2 Million Mothers and Babies by 2030

Melinda French Gates and Bill Gates call for urgent action to advance progress on the UN's Sustainable Development Goals and shine a spotlight on reducing maternal and child mortality SEATTLE, Sept. 12, 2023 /PRNewswire/ -- The Bill & Melinda Gates Foundation today released its seventh annual Go...

2023-09-12 12:01 1800

When is it too late for a 'fairy tale ending' for women electing to freeze their oocytes?

ADELAIDE, Australia, Sept. 12, 2023 /PRNewswire/ -- Around the world, soaring numbers of women are electing to freeze their eggs to preserve their fertility, and many do so in anticipation of a "fairy tale ending" with the birth of a healthy baby. However, a reality check is needed to manage t...

2023-09-12 09:28 1620

MGI Launches the DCS Lab Initiative to Expand Global Omics Access and Capabilities

SHENZHEN, China, Sept. 11, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced the DCS Lab Initiative to help facilitate large-scale leading multi-omics laboratories and spur critical scientific research. Under the initiative, ...

2023-09-11 19:43 1176

IPMG Drives Health Transformation and Strengthens Indonesia's Economy Through Efforts to Accelerate Access to Innovative Medicines and Vaccines, also Partnerships

JAKARTA,  Indonesia, Sept. 11, 2023 /PRNewswire/ -- The research and development-based multinational pharmaceutical industry association, the International Pharmaceutical Manufacturers Group (IPMG) is always committed to supporting and encouraging advocacy and transformation of Government policie...

2023-09-11 18:52 2095

KT&G and the Indonesian Ministry of Investment jointly conduct investment support ceremony for KT&G's new manufacturing plant construction in Indonesia

* The new manufacturing plant is expected to commence production in 2026…expected to serve as an export hub SEOUL, South Korea, Sept. 11, 2023 /PRNewswire/ -- KT&G Corporation ("KT&G") (KRX:033780) conducted an investment support ceremony with the Indonesian Ministry of Investment and obtained ...

2023-09-11 17:29 4683

Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer

AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment ofSaulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience...

2023-09-11 15:00 1351

Can we really make a difference in reducing the heartbreak of millions of miscarriages each year?

ADELAIDE, Australia, Sept. 11, 2023 /PRNewswire/ -- Globally, one in six pregnancies end in miscarriage, which is generally defined as the loss of an intrauterine pregnancy before viability. This equates to an estimated 23 million miscarriages every year, or over 40 miscarriages per minute. Th...

2023-09-11 14:58 1620

Biosyngen received FDA approval for Phase I/II Clinical Trials for BRL03, targeting Lung Cancer, Gastric Cancer and other advanced Solid Tumors

SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- On September 9th, 2023, Biosyngen Pte Ltd (hereafter as "Biosyngen") announced that the U.S. FDA has cleared the Investigational New Drug (IND) application for Phase I/II clinical trial ofBRL03 for the treatment of lung cancer, gastric cancer and other ad...

2023-09-11 14:53 1475

PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells)

IRVINE, Calif., Sept. 11, 2023 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first dose cohort of its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma (r/r B-NHL) clinical ...

2023-09-11 12:05 2247

The social, economic and political reality for many girls cast aside in cultural gender selection

ADELAIDE, Australia, Sept. 11, 2023 /PRNewswire/ -- Deep rooted historical preference for sons over daughters continues to be customary in some East and South Asian countries devaluing women and posing long term threats to society. This disturbing situation, often leading to female feticide – o...

2023-09-11 10:35 1714
1 ... 125126127128129130131 ... 581